- In April 2025, Diag-Nose.io, an Australian company, secured seed funding to advance its AI-driven precision management for chronic pulmonary disorders, showcasing AI's growing role in specialized home-based care. This initiative highlights the increasing investment in AI to personalize and enhance remote management of complex conditions
- In March 2025, Researchers at the University of Cambridge unveiled an AI tool for rapid coeliac disease diagnosis using image analysis, demonstrating AI's potential to expedite diagnostics within home or point-of-care settings, improving accessibility and reducing wait times for patients needing timely results
- In March 2025, Akido Labs launched ScopeAI in collaboration with the Independent Drivers Guild and Workers Benefit Fund, providing AI-powered medical care to New York City's ride-share drivers. This initiative indicates a trend towards leveraging AI to extend healthcare access to underserved populations in their everyday environments
- In February 2025, UnitedHealth acquired LHC Group, a major in-home healthcare service provider, signaling a growing consolidation and investment by large healthcare organizations in expanding their home-based care capabilities, likely integrating AI for enhanced efficiency and patient management
- In January 2025 DUOS launched Chat 2.0, an advanced AI platform designed for the geriatric population, featuring at HLTH 2024. This platform aims to make healthcare more accessible, actionable, and personalized for seniors at home, addressing the increasing need for AI-driven support for aging in place
